| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14737159.2017.1271715 |
| P698 | PubMed publication ID | 27936985 |
| P50 | author | André Pèlegrin | Q88939578 |
| P2093 | author name string | Muriel Brengues | |
| David Azria | |||
| Céline Bourgier | |||
| Ariane Lapierre | |||
| Mahmut Özsahin | |||
| P2860 | cites work | Megabase chromatin domains involved in DNA double-strand breaks in vivo | Q24680284 |
| Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences | Q26786129 | ||
| Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research | Q27023686 | ||
| GammaH2AX and cancer | Q29614974 | ||
| Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients | Q31116483 | ||
| Sources of variation in patient response to radiation treatment | Q31926025 | ||
| Chemokine-mobilized adult stem cells; defining a better hematopoietic graft | Q33623545 | ||
| Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs) | Q33683487 | ||
| Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study | Q34240634 | ||
| The tumor-immune microenvironment and response to radiation therapy | Q34444598 | ||
| Evaluation of different biomarkers to predict individual radiosensitivity in an inter-laboratory comparison--lessons for future studies | Q34460363 | ||
| Sensing and repairing DNA double-strand breaks | Q34642563 | ||
| Use of archived specimens in evaluation of prognostic and predictive biomarkers | Q35007222 | ||
| Effects of radiation on normal tissue: consequences and mechanisms. | Q35215796 | ||
| The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention | Q36077772 | ||
| T lymphocytes and normal tissue responses to radiation | Q36244299 | ||
| Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial. | Q36437589 | ||
| Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition | Q36646481 | ||
| Current management for late normal tissue injury: radiation-induced fibrosis and necrosis | Q36774557 | ||
| Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial | Q37002898 | ||
| Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype | Q37162103 | ||
| Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin | Q37261069 | ||
| Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer | Q37283218 | ||
| Use of normal tissue complication probability models in the clinic | Q37695533 | ||
| Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy. | Q38286519 | ||
| Radiogenomics: the search for genetic predictors of radiotherapy response | Q38294605 | ||
| Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples. | Q38436110 | ||
| Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity | Q38545794 | ||
| Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity | Q38794946 | ||
| In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study. | Q38825281 | ||
| Prediction of radiation-induced toxicity by in vitro radiosensitivity of lymphocytes in prostate cancer patients | Q38916634 | ||
| Correlation of in vitro lymphocyte radiosensitivity and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer | Q39518965 | ||
| CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients | Q40378736 | ||
| Analysis of treatment in childhood leukemia. IV.The critical association between dose fractionation and immunosuppression induced by cranial irradiation | Q40517527 | ||
| A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. | Q40976746 | ||
| Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity | Q41089746 | ||
| Mitochondrial reactive oxygen species regulate transforming growth factor-β signaling | Q41921136 | ||
| One Size Fits All: Does the Dogma Stand in Radiation Oncology? | Q42399226 | ||
| Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial | Q42648268 | ||
| Ex Vivo Apoptosis in CD8+ Lymphocytes Predicts Rectal Cancer Patient Outcome. | Q42713442 | ||
| Comparative analysis of three functional predictive assays in lymphocytes of patients with breast and gynaecological cancer treated by radiotherapy | Q43119692 | ||
| Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives | Q43596090 | ||
| Caffeine-induced radiosensitization is independent of nonhomologous end joining of DNA double-strand breaks | Q44324288 | ||
| Role of CD4 and CD8 T-lymphocytes, B-lymphocytes and Natural Killer cells in the prediction of radiation-induced late toxicity in cervical cancer patients | Q44915646 | ||
| REporting recommendations for tumor MARKer prognostic studies (REMARK). | Q46099462 | ||
| Reduced activity of double-strand break repair genes in prostate cancer patients with late normal tissue radiation toxicity | Q46327360 | ||
| ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy | Q46843010 | ||
| Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. | Q50734229 | ||
| Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. | Q50946282 | ||
| Tissue-based class control: the other side of tolerance. | Q51018682 | ||
| Biodosimetry using radiation-induced micronuclei in skin fibroblasts. | Q51432880 | ||
| Variation in telangiectasia predisposing genes is associated with overall radiation toxicity. | Q53164065 | ||
| In vivo versus in vitro individual radiosensitivity analysed in healthy donors and in prostate cancer patients with and without severe side effects after radiotherapy. | Q53184648 | ||
| Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. | Q53570400 | ||
| DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy. | Q54369251 | ||
| Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study | Q57618766 | ||
| Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity | Q59066708 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 119-127 | |
| P577 | publication date | 2016-12-22 | |
| P1433 | published in | Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare | Q15756305 |
| P1476 | title | T lymphocytes to predict radiation-induced late effects in normal tissues | |
| P478 | volume | 17 |
| Q64075544 | Assessing Radiosensitivity of Bladder Cancer : A 2D vs. 3D Approach |
| Q55188975 | Bax/Bcl-2 expression ratio in prediction of response to breast cancer radiotherapy. |
| Q30234489 | Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era. |
| Q54965448 | Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator. |
Search more.